midazolam
Commercial- Indications
- Status epilepticus
Company intelligence / Profile preview
Rafa Laboratories has a long-standing commercial presence in Israel with approved products including autoinjectors for emergency use and status epilepticus treatments. Their atropine autoinjectors are FDA-approved for both adult and pediatric use. The company supplies medical countermeasures globally to governments and military forces, with cGMP-compliant manufacturing facilities.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rafa Laboratories.